AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Statistics

Total Valuation

AprilBio has a market cap or net worth of KRW 775.16 billion. The enterprise value is 686.24 billion.

Market Cap	775.16B
Enterprise Value	686.24B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

AprilBio has 22.57 million shares outstanding. The number of shares has increased by 4.69% in one year.

Current Share Class	22.57M
Shares Outstanding	22.57M
Shares Change (YoY)	+4.69%
Shares Change (QoQ)	+2.22%
Owned by Insiders (%)	30.99%
Owned by Institutions (%)	11.88%
Float	15.34M

Valuation Ratios

The trailing PE ratio is 807.92 and the forward PE ratio is 107.34.

PE Ratio	807.92
Forward PE	107.34
PS Ratio	86.38
PB Ratio	8.63
P/TBV Ratio	8.68
P/FCF Ratio	31.90
P/OCF Ratio	31.57
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	715.24
EV / Sales	76.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	28.24

Financial Position

The company has a current ratio of 12.92, with a Debt / Equity ratio of 0.04.

Current Ratio	12.92
Quick Ratio	12.87
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	0.14
Interest Coverage	-1.49

Financial Efficiency

Return on equity (ROE) is 1.16% and return on invested capital (ROIC) is -1.10%.

Return on Equity (ROE)	1.16%
Return on Assets (ROA)	-0.99%
Return on Invested Capital (ROIC)	-1.10%
Return on Capital Employed (ROCE)	-1.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.83% in the last 52 weeks. The beta is 1.70, so AprilBio's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	+31.83%
50-Day Moving Average	24,330.20
200-Day Moving Average	18,561.85
Relative Strength Index (RSI)	74.93
Average Volume (20 Days)	1,540,039

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AprilBio had revenue of KRW 8.97 billion and earned 959.45 million in profits. Earnings per share was 6.92.

Revenue	8.97B
Gross Profit	8.96B
Operating Income	-1.55B
Pretax Income	959.45M
Net Income	959.45M
EBITDA	-853.99M
EBIT	-1.55B
Earnings Per Share (EPS)	6.92

Balance Sheet

The company has 92.24 billion in cash and 3.32 billion in debt, giving a net cash position of 88.92 billion or 3,940.34 per share.

Cash & Cash Equivalents	92.24B
Total Debt	3.32B
Net Cash	88.92B
Net Cash Per Share	3,940.34
Equity (Book Value)	89.83B
Book Value Per Share	3,987.74
Working Capital	87.11B

Cash Flow

In the last 12 months, operating cash flow was 24.55 billion and capital expenditures -250.71 million, giving a free cash flow of 24.30 billion.

Operating Cash Flow	24.55B
Capital Expenditures	-250.71M
Free Cash Flow	24.30B
FCF Per Share	1,076.93

Margins

Gross margin is 99.81%, with operating and profit margins of -17.24% and 10.69%.

Gross Margin	99.81%
Operating Margin	-17.24%
Pretax Margin	10.69%
Profit Margin	10.69%
EBITDA Margin	-9.52%
EBIT Margin	-17.24%
FCF Margin	270.81%

Dividends & Yields

AprilBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.69%
Shareholder Yield	n/a
Earnings Yield	0.12%
FCF Yield	3.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 31, 2023. It was a forward split with a ratio of 2.

Last Split Date	Oct 31, 2023
Split Type	Forward
Split Ratio	2

Scores

AprilBio has an Altman Z-Score of 32.63 and a Piotroski F-Score of 4.

Altman Z-Score	32.63
Piotroski F-Score	4